Bioequivalence Study of Finasteride 5 mg Tablet Formulations Under Fasting Conditions
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to evaluate the relative bioavailability of the test
formulation of finasteride 5 mg tablets (Dr. Reddy's Laboratories Limited) with the reference
formulation PROSCAR® 5 mg Tablet (Merck & Co., Inc.)under fasting conditions in healthy adult
male subjects.